In a study with NSCLC cells which constitutively-expressed activated MEK/ERK, no increase in paclitaxel-induced apoptosis was observed when the cells were treated with a MEK inhibitor [81]. Here, MAP2K7 is linked to non-small cell lung carcinoma.